<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(1)</volume><submitter>Freuer D</submitter><pubmed_abstract>Emerging evidence from observational studies suggests an increased risk of Parkinson's disease (PD) in patients with inflammatory bowel disease (IBD). However, to date it is not clear whether a causal relationship exists. To investigate whether IBD is causally related to PD, a two-sample Mendelian randomization study was carried out. Independent genetic instruments from the largest available genome-wide association study (GWAS) for IBD (7045 cases, 456,327 controls) including European participants were used to investigate the association with PD (56,306 cases; 1.4 million controls). The results were validated by using a second IBD sample (12,882 cases; 21,770 controls) including the main subtypes ulcerative colitis (UC; 6968 cases; 20,464 controls) and Crohn's disease (CD; 5956 cases; 14,9</pubmed_abstract><journal>NPJ Parkinson's disease</journal><pagination>55</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9085764</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Association between inflammatory bowel disease and Parkinson's disease: A Mendelian randomization study.</pubmed_title><pmcid>PMC9085764</pmcid><pubmed_authors>Meisinger C</pubmed_authors><pubmed_authors>Freuer D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association between inflammatory bowel disease and Parkinson's disease: A Mendelian randomization study.</name><description>Emerging evidence from observational studies suggests an increased risk of Parkinson's disease (PD) in patients with inflammatory bowel disease (IBD). However, to date it is not clear whether a causal relationship exists. To investigate whether IBD is causally related to PD, a two-sample Mendelian randomization study was carried out. Independent genetic instruments from the largest available genome-wide association study (GWAS) for IBD (7045 cases, 456,327 controls) including European participants were used to investigate the association with PD (56,306 cases; 1.4 million controls). The results were validated by using a second IBD sample (12,882 cases; 21,770 controls) including the main subtypes ulcerative colitis (UC; 6968 cases; 20,464 controls) and Crohn's disease (CD; 5956 cases; 14,9</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2026-03-27T15:18:03.771Z</modification><creation>2025-04-04T19:09:55.994Z</creation></dates><accession>S-EPMC9085764</accession><cross_references><pubmed>35534507</pubmed><doi>10.1038/s41531-022-00318-7</doi></cross_references></HashMap>